1. Abuzeid MI, Nassar Z, Massaad Z, Weiss M, Ashraf M, Fakih M. Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 2003; 18: 370-373. [
DOI:10.1093/humrep/deg074]
2. Kumar P,Sait SF,Sharma A,Kumar M. Ovarian hyperstimulation syndrome. Hum Reprod 2011; 4: 70-75. [
DOI:10.4103/0974-1208.86080]
3. Hock DL, Seifer DB. Ovarian hyperstimulation syndrome. Infertil Reprod Med Clin North AM 2000; 399-417.
4. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992; 58: 249-261. [
DOI:10.1016/S0015-0282(16)55188-7]
5. Manaka C, Araki S, Motoyama M. Management of ovarian hyperstimulation syndrome (in Japanese). Jpn J Fertil Steril 1995; 40: 427-432.
6. Balasch J, Fabregues F, Arroyo V. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet Gynecol Scand 1996; 75: 662-667. [
DOI:10.3109/00016349609054694]
7. Brinsden PI, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102: 767-772. [
DOI:10.1111/j.1471-0528.1995.tb10840.x]
8. Ferraretti AP, Gianaroli L, Diotallevi L, Festi C, Trounson A. Dopamine treatment for severe ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 180-183. [
DOI:10.1093/oxfordjournals.humrep.a137613]
9. Al-Shawaf T, Grudzinskas JG. Prevention and treatment of ovarian hyperstimulation syndrome. Best Pract Res Clin Obstet Gynaecol 2003; 17: 249-261. [
DOI:10.1016/S1521-6934(02)00127-X]
10. Toshimitsu K, Shigeo A, Hisanori M,Shuichi O, Masaaki S, Hiroaki S, et al. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 2000; 15: 113-117. [
DOI:10.1093/humrep/15.1.113]
11. Friedman CI, Schmidt GE, Chang FE. Severe ovarian hyperstimulation following follicular aspiration. Am J Obstet Gynecol 1984; 150: 436-437. [
DOI:10.1016/S0002-9378(84)80158-1]
12. Aflatoonian A, Ghandi S, Tabibnejad N. Comparison of coasting with Cabergoline administration for prevention of early severe OHSS in ART cycles. Iran J Reprod Med 2008; 6: 51-55.
13. Annick D, Corinne C, Serge R. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle. Fertil Steril 2001; 76: 844-846. [
DOI:10.1016/S0015-0282(01)02007-6]
14. Endo T, Kitajima Y, Hayashi T, Fujii M, Hata H, Azumaguchi A. Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion. Fertil Steril 2004; 82:1449-1451. [
DOI:10.1016/j.fertnstert.2004.04.045]
15. Chan CC, Yin CS, Lan SC, Chen IC, Wu GJ. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome. J Chin Med Assoc 2004; 67: 197-199.